Medical Devices Series B Investors & VC Firms
515 firms in this list, with a median first check of $540K. 108 of them lead rounds. Generated from verified public data and updated continuously.
Texas Ventures
HoustonSeed–Late Stage
6 people
PM Equity Partner
LausanneSeries A–Growth$2M – $50M
11 people
Launch Tennessee
NashvillePre-Seed–Series B
1 person
Ennovation Ventures
NanjingSeed–Series B
13 people
Innvotec Ltd.
LondonSeries A–Series B$317.5K – $635K
4 people
Amzak Health
New YorkSeed–Growth
5 people
Sound Bioventures
MalmöSeed–Growth
9 people
JStar Capital Investments
AustinSeed–Series C
13 people
Shepherd Ventures
San DiegoSeries A–Late Stage$750K – $3M
6 people
Black Diamond Ventures
GlendalePre-Seed–Growth$2M – $10M
8 people
Kama Flow
MoscowSeed–Growth
4 people
Truffle Capital
ParisSeed–Growth$5M – $15M
7 people
Global Health Investment Corporation
New YorkSeed–Series B
5 people
Partners Investment Co. Ltd.
SeoulSeries A–Late Stage
11 people
Ameba Capital
ShanghaiSeed–Growth
10 people
Healthier Capital
Menlo ParkSeed–Series B
9 people
Fresenius Medical Care Ventures
Bad HomburgSeed–Late Stage
7 people
Thursday Ventures
BrandonSeed–Series C
7 people
OCV Partners
Los AngelesSeed–Series C
6 people
CCV Capital
BeijingSeed–Series B
14 people
Joy Capital
BeijingSeed–Growth
6 people
Vital Venture Capital
WashingtonSeries A–Growth$1M – $3M
5 people
Access Biotechnology
New YorkSeed–Late Stage
3 people
Wallonie Entreprendre
LiègePre-Seed–Growth
9 people
Related lists
Series B Investors & VC Firms (2954)Series B Investors & VC Firms in North America (1744)Medical Devices Investors & VC Firms (1659)Series B Investors & VC Firms in United States (1578)Medical Devices Seed Investors & VC Firms (1321)Medical Devices Series A Investors & VC Firms (1139)Medical Devices Investors & VC Firms in North America (1090)Series B Investors & VC Firms in Europe (1078)SaaS Series B Investors & VC Firms (1075)Series B Investors & VC Firms in Global (1068)
Data sourced from public filings and firms' own websites — see our methodology.














































































